Literature DB >> 18556244

Cigarette smoking and subsequent risk of lung cancer in men and women: analysis of a prospective cohort study.

Neal D Freedman1, Michael F Leitzmann, Albert R Hollenbeck, Arthur Schatzkin, Christian C Abnet.   

Abstract

BACKGROUND: Whether women are more susceptible than men to lung cancer caused by cigarette smoking has been controversial. To address this question, we aimed to compare incidence rates of lung cancer by stratum of smoking use in men and women of the National Institutes of Health (NIH)-AARP cohort.
METHODS: Participants in the NIH-AARP Diet and Health study responded to a postal questionnaire between Oct 13, 1995, and May 6, 1996, and were followed up until Dec 31, 2003. The questionnaire asked participants about their past and current smoking status, demographics, alcohol intake, tobacco smoking, physical activity, and included a food-frequency questionnaire of 124 items. Incident lung cancers were identified by linkage to individual state cancer registries. We present age-standardised incidence rates for cancer and multivariate hazard ratios (HRs) adjusted for potential confounders, with 95% CIs. This study conforms to the STROBE guidelines.
FINDINGS: 279 214 men and 184 623 women from eight states in the USA aged 50-71 years at study baseline were included in this analysis. During follow-up, lung cancers occurred in 4097 men and 2237 women. Incidence rates were 20.3 (95% CI 16.3-24.3) per 100 000 person-years in men who had never smoked (99 cancers) and 25.3 (21.3-29.3) in women who had never smoked (152 cancers); for this group, the adjusted HR for lung cancer was 1.3 (1.0-1.8) for women compared with men. Smoking was associated with increased risk of lung cancer in men and women. The incidence rate of current smokers who smoked more than two packs per day was 1259.2 (1035.0-1483.3) in men and 1308.9 (924.2-1693.6) in women. In current smokers, in a model adjusted for typical smoking dose, the HR was 0.9 (0.8-0.9) for women compared with men. For former smokers, in a model adjusted for years of cessation and typical smoking dose, the HR was 0.9 (0.9-1.0) for women compared with men. Incidence rates of adenocarcinoma, small-cell carcinoma, and undifferentiated tumours were similar in men and women; incidence rates of squamous tumours in men were about twice that in women.
INTERPRETATION: Our findings suggest that women are not more susceptible than men to the carcinogenic effects of cigarette smoking in the lung. In smokers, incidence rates tended to be higher in men than women with comparable smoking histories, but differences were modest; smoking was strongly associated with lung cancer risk in both men and women. Future studies should confirm whether incidence rates are indeed higher in women who have never smoked than in men who have never smoked.

Entities:  

Mesh:

Year:  2008        PMID: 18556244      PMCID: PMC2601691          DOI: 10.1016/S1470-2045(08)70154-2

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


  37 in total

1.  Women and lung cancer: gender equality at a crossroad?

Authors:  Alfred I Neugut; Judith S Jacobson
Journal:  JAMA       Date:  2006-07-12       Impact factor: 56.272

2.  Point and interval estimates of partial population attributable risks in cohort studies: examples and software.

Authors:  D Spiegelman; E Hertzmark; H C Wand
Journal:  Cancer Causes Control       Date:  2007-03-26       Impact factor: 2.506

3.  Environmental tobacco smoke and mortality in Chinese women who have never smoked: prospective cohort study.

Authors:  Wanqing Wen; Xiao Ou Shu; Yu-Tang Gao; Gong Yang; Qi Li; Honglan Li; Wei Zheng
Journal:  BMJ       Date:  2006-07-12

4.  Women's susceptibility to tobacco carcinogens and survival after diagnosis of lung cancer.

Authors:  Claudia I Henschke; Rowena Yip; Olli S Miettinen
Journal:  JAMA       Date:  2006-07-12       Impact factor: 56.272

5.  Serum cotinine level as predictor of lung cancer risk.

Authors:  Paolo Boffetta; Sarah Clark; Min Shen; Randi Gislefoss; Richard Peto; Aage Andersen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-06       Impact factor: 4.254

6.  International lung cancer trends by histologic type: male:female differences diminishing and adenocarcinoma rates rising.

Authors:  Susan S Devesa; Freddie Bray; A Paloma Vizcaino; D Max Parkin
Journal:  Int J Cancer       Date:  2005-11-01       Impact factor: 7.396

7.  Nicotine regulates smoking patterns.

Authors:  M V Djordjevic; D Hoffmann; I Hoffmann
Journal:  Prev Med       Date:  1997 Jul-Aug       Impact factor: 4.018

8.  Lung cancer death rates in lifelong nonsmokers.

Authors:  Michael J Thun; S Jane Henley; David Burns; Ahmedin Jemal; Thomas G Shanks; Eugenia E Calle
Journal:  J Natl Cancer Inst       Date:  2006-05-17       Impact factor: 13.506

9.  Lung cancer incidence in never smokers.

Authors:  Heather A Wakelee; Ellen T Chang; Scarlett L Gomez; Theresa H Keegan; Diane Feskanich; Christina A Clarke; Lars Holmberg; Lee C Yong; Laurence N Kolonel; Michael K Gould; Dee W West
Journal:  J Clin Oncol       Date:  2007-02-10       Impact factor: 44.544

10.  Trends in the exposure of nonsmokers in the U.S. population to secondhand smoke: 1988-2002.

Authors:  James L Pirkle; John T Bernert; Samuel P Caudill; Connie S Sosnoff; Terry F Pechacek
Journal:  Environ Health Perspect       Date:  2006-06       Impact factor: 9.031

View more
  82 in total

1.  Targeting the estrogen pathway for the treatment and prevention of lung cancer.

Authors:  Timothy F Burns; Laura P Stabile
Journal:  Lung Cancer Manag       Date:  2014-02-01

2.  Association between the CpG island methylator phenotype and its prognostic significance in primary pulmonary adenocarcinoma.

Authors:  Young Wha Koh; Sung-Min Chun; Young-Soo Park; Joon Seon Song; Geon Kook Lee; Shin Kwang Khang; Se Jin Jang
Journal:  Tumour Biol       Date:  2016-02-11

3.  Reproductive and hormonal factors and the risk of nonsmall cell lung cancer.

Authors:  Cari L Meinhold; Amy Berrington de González; Elise D Bowman; Alina V Brenner; Raymond T Jones; James V Lacey; Christopher A Loffredo; Donna Perlmutter; Sara J Schonfeld; Glenwood E Trivers; Curtis C Harris
Journal:  Int J Cancer       Date:  2011-03-15       Impact factor: 7.396

4.  Higher Lung Cancer Incidence in Young Women Than Young Men in the United States.

Authors:  Ahmedin Jemal; Kimberly D Miller; Jiemin Ma; Rebecca L Siegel; Stacey A Fedewa; Farhad Islami; Susan S Devesa; Michael J Thun
Journal:  N Engl J Med       Date:  2018-05-24       Impact factor: 91.245

Review 5.  European and North American lung cancer screening experience and implications for pulmonary nodule management.

Authors:  Arjun Nair; David M Hansell
Journal:  Eur Radiol       Date:  2011-08-10       Impact factor: 5.315

6.  Estrogen receptor expression and gene promoter methylation in non-small cell lung cancer - a short report.

Authors:  Xavier Tekpli; Vidar Skaug; Rita Bæra; David H Phillips; Aage Haugen; Steen Mollerup
Journal:  Cell Oncol (Dordr)       Date:  2016-08-29       Impact factor: 6.730

7.  Novel compound 1,3-bis (3,5-dichlorophenyl) urea inhibits lung cancer progression.

Authors:  Sharad S Singhal; James Figarola; Jyotsana Singhal; Lokesh Nagaprashantha; David Berz; Samuel Rahbar; Sanjay Awasthi
Journal:  Biochem Pharmacol       Date:  2013-10-04       Impact factor: 5.858

Review 8.  Lifestyle as risk factor for cancer: Evidence from human studies.

Authors:  Naghma Khan; Farrukh Afaq; Hasan Mukhtar
Journal:  Cancer Lett       Date:  2010-01-18       Impact factor: 8.679

9.  Are women who smoke at higher risk for lung cancer than men who smoke?

Authors:  Sara De Matteis; Dario Consonni; Angela C Pesatori; Andrew W Bergen; Pier Alberto Bertazzi; Neil E Caporaso; Jay H Lubin; Sholom Wacholder; Maria Teresa Landi
Journal:  Am J Epidemiol       Date:  2013-02-20       Impact factor: 4.897

10.  Hepatitis C virus infection and risk of cancer: a population-based cohort study.

Authors:  Lars Haukali Omland; Dora Körmendiné Farkas; Peter Jepsen; Niels Obel; Lars Pedersen
Journal:  Clin Epidemiol       Date:  2010-08-09       Impact factor: 4.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.